Introduction Enhanced recovery after surgery (ERAS) programs have been developed to
improve patient outcomes, accelerate recovery after surgery, and reduce healthcare costs …

Methylene blue (MB) is a well-established drug with a long history of use, owing to its
diverse range of use and its minimal side effect profile. MB has been used classically for the …

Purpose The optimal ventilatory settings in patients after cardiac arrest and their association
with outcome remain unclear. The aim of this study was to describe the ventilatory settings …

Cardiac arrest is a leading cause of death in developed countries. Although a majority of
cardiac arrest patients die during the acute event, a substantial proportion of cardiac arrest …

Importance Therapeutic hypothermia is used for patients following both out-of-hospital and
in-hospital cardiac arrest. However, randomized trials on its efficacy for the in-hospital …

Purpose We aimed to evaluate post-resuscitation care, implementation of therapeutic
hypothermia (TH) and outcomes of intensive care unit (ICU)-treated out-of-hospital cardiac …

Neonatal hypoxic-ischemic (HI) injury is a severe complication often leading to neonatal
death and long-term neurobehavioral deficits in children. Currently, the only treatment option …

Background G-protein-coupled estrogen receptor (GPER/GPR30) is a novel membrane-
associated estrogen receptor that can induce rapid kinase signaling in various cells …

Hypothermia is currently the only approved therapy for global cerebral ischemia (GCI) after
cardiac arrest; however, it unfortunately has multiple adverse effects. As a noninvasive …

The current study examined efficacy of a small Tat (trans-activator of transcription)-
conjugated peptide activator of the Nrf2 (nuclear factor-E2-related factor-2) antioxidant/cell …